MEDICAL PRODUCTS LABORATORIES, INC.
PHILADELPHIA, PA

Medical Products Laboratories, Inc. (MPL), founded by Dr. Harold G. Stone, is a distinguished company that specializes in the research and manufacturing of fluoride pharmaceuticals with over four decades of dedicated experience. Established with a strong partnership from notable experts at the National Institute of Dental Research, MPL has pioneered nationwide caries prevention programs facilitated through school-based fluoride mouth rinse initiatives. Today, it holds the title as the largest manufacturer of such products within the United States, serving schools, clinics, government agencies, and international markets alike. Known for its innovation in pharmaceuticals, MPL boasts over 80 years of cumulative experience, enabling the company to offer comprehensive solutions in quality product formulation and manufacturing. The company maintains an impeccable reputation in production schedules, stringent quality controls, and minimal lead times, achieved through extensive machinery expertise and experienced workforce. MPL operates as a cGMP-compliant contract manufacturer committed to delivering top-tier research & development, manufacturing, packaging, and testing services for pharmaceutical products. Positioned at the cutting edge of innovation with competitive pricing models, MPL's drive is powered by dedicated customer service teams composed of proficient professionals. The company holds its headquarters in Philadelphia, PA, with operations registered in Palm Beach County, Florida. Noteworthy contact details include a main telephone number (800) 523-0191 and additional lines for corporate inquiries. Their official website is medicalproductslaboratories.com, where stakeholders can explore further about their services and offerings. Key personnel at MPL include Elliot Stone as President, Margaret Kelly in an undisclosed position, and Mark Sherr serving as Chief Financial Officer (CFO). Since its inception on January 28, 2010, the corporation has navigated through its events with resilience, including a reinstatement on February 19, 2014. The company’s filing number is F10000000502, with the last annual report filed for the year 2024.